52 related articles for article (PubMed ID: 9843385)
21. Roles of key active-site residues in flavocytochrome P450 BM3.
Noble MA; Miles CS; Chapman SK; Lysek DA; MacKay AC; Reid GA; Hanzlik RP; Munro AW
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):371-9. PubMed ID: 10191269
[TBL] [Abstract][Full Text] [Related]
22. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
23. Crystal structure of inhibitor-bound P450BM-3 reveals open conformation of substrate access channel.
Haines DC; Chen B; Tomchick DR; Bondlela M; Hegde A; Machius M; Peterson JA
Biochemistry; 2008 Mar; 47(12):3662-70. PubMed ID: 18298086
[TBL] [Abstract][Full Text] [Related]
24. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
Roitel O; Scrutton NS; Munro AW
Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
[TBL] [Abstract][Full Text] [Related]
25. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
[TBL] [Abstract][Full Text] [Related]
26. Imidazolyl carboxylic acids as mechanistic probes of flavocytochrome P-450 BM3.
Noble MA; Quaroni L; Chumanov GD; Turner KL; Chapman SK; Hanzlik RP; Munro AW
Biochemistry; 1998 Nov; 37(45):15799-807. PubMed ID: 9843385
[TBL] [Abstract][Full Text] [Related]
27. Fatty acid metabolism, conformational change, and electron transfer in cytochrome P-450(BM-3).
Li H; Poulos TL
Biochim Biophys Acta; 1999 Nov; 1441(2-3):141-9. PubMed ID: 10570242
[TBL] [Abstract][Full Text] [Related]
28. P450 BM3: the very model of a modern flavocytochrome.
Munro AW; Leys DG; McLean KJ; Marshall KR; Ost TW; Daff S; Miles CS; Chapman SK; Lysek DA; Moser CC; Page CC; Dutton PL
Trends Biochem Sci; 2002 May; 27(5):250-7. PubMed ID: 12076537
[TBL] [Abstract][Full Text] [Related]
29. Flavocytochrome P450 BM3: an update on structure and mechanism of a biotechnologically important enzyme.
Warman AJ; Roitel O; Neeli R; Girvan HM; Seward HE; Murray SA; McLean KJ; Joyce MG; Toogood H; Holt RA; Leys D; Scrutton NS; Munro AW
Biochem Soc Trans; 2005 Aug; 33(Pt 4):747-53. PubMed ID: 16042591
[TBL] [Abstract][Full Text] [Related]
30. Flavin-containing heme enzymes.
Mowat CG; Gazur B; Campbell LP; Chapman SK
Arch Biochem Biophys; 2010 Jan; 493(1):37-52. PubMed ID: 19850002
[TBL] [Abstract][Full Text] [Related]
31. Flavocytochrome P450 BM3 substrate selectivity and electron transfer in a model cytochrome P450.
Munro AW; Noble MA; Ost TW; Green AJ; McLean KJ; Robledo L; Miles CS; Murdoch J; Chapman SK
Subcell Biochem; 2000; 35():297-315. PubMed ID: 11192726
[No Abstract] [Full Text] [Related]
32. Flavocytochrome P-450 BM3: a paradigm for the analysis of electron transfer and its control in the P-450s.
Munro AW; Noble MA; Miles CS; Daff SN; Green AJ; Quaroni L; Rivers S; Ost TW; Reid GA; Chapman SK
Biochem Soc Trans; 1999 Feb; 27(2):190-6. PubMed ID: 10093732
[No Abstract] [Full Text] [Related]
33. Enzymatic oxidation of xenobiotic chemicals.
Guengerich FP
Crit Rev Biochem Mol Biol; 1990; 25(2):97-153. PubMed ID: 2183970
[TBL] [Abstract][Full Text] [Related]
34. Mechanism-based probes of the topology and function of fatty acid hydroxylases.
Ortiz de Montellano PR; Chan WK; Tuck SF; Kaikaus RM; Bass NM; Peterson JA
FASEB J; 1992 Jan; 6(2):695-9. PubMed ID: 1537458
[TBL] [Abstract][Full Text] [Related]
35. Flavocytochrome P450 BM3 and the origin of CYP102 fusion species.
Girvan HM; Waltham TN; Neeli R; Collins HF; McLean KJ; Scrutton NS; Leys D; Munro AW
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1173-7. PubMed ID: 17073779
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
